175 related articles for article (PubMed ID: 28582340)
1. A Report of Ovarian Sertoli-Leydig Cell Tumors With Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature.
Al-Hussaini M; Al-Othman Y; Hijazi E; McCluggage WG
Int J Gynecol Pathol; 2018 May; 37(3):275-283. PubMed ID: 28582340
[TBL] [Abstract][Full Text] [Related]
2. Raised serum alpha-fetoprotein in Sertoli-Leydig cell tumor (androblastoma) of ovary: report of two cases.
Chadha S; Honnebier WJ; Schaberg A
Int J Gynecol Pathol; 1987; 6(1):82-8. PubMed ID: 2437064
[TBL] [Abstract][Full Text] [Related]
3. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
Virk R; Lu D
Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
[TBL] [Abstract][Full Text] [Related]
4. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
[TBL] [Abstract][Full Text] [Related]
5. Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.
Mooney EE; Nogales FF; Tavassoli FA
Hum Pathol; 1999 Jun; 30(6):611-7. PubMed ID: 10374766
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report.
Watanabe T; Yamada H; Morimura Y; Abe M; Motoyama T; Sato A
J Obstet Gynaecol Res; 2008 Jun; 34(3):418-21. PubMed ID: 18588618
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.
Horta M; Cunha TM; Marques RC; Félix A
J Radiol Case Rep; 2014 Nov; 8(11):30-41. PubMed ID: 25926909
[TBL] [Abstract][Full Text] [Related]
8. Expression of alpha-fetoprotein by ovarian Sertoli-Leydig cell tumors. Case report and review of the literature.
Hammad A; Jasnosz KM; Olson PR
Arch Pathol Lab Med; 1995 Nov; 119(11):1075-9. PubMed ID: 7487411
[TBL] [Abstract][Full Text] [Related]
9. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Sertoli-Leydig cell tumor with elevated serum alpha-fetoprotein.
Motoyama I; Watanabe H; Gotoh A; Takeuchi S; Tanabe N; Nashimoto I
Cancer; 1989 May; 63(10):2047-53. PubMed ID: 2467733
[TBL] [Abstract][Full Text] [Related]
11. Sertoli Leydig cell tumor with malignant heterologous elements and raised alpha-fetoprotein: a case report.
Singh ZN; Singh MK; Chopra P
J Obstet Gynaecol Res; 1996 Dec; 22(6):595-8. PubMed ID: 9037950
[TBL] [Abstract][Full Text] [Related]
12. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract][Full Text] [Related]
13. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
14. Sertoli-Leydig cell tumor of ovary in children: A report of two cases, including retiform variant.
Sarkar P; Sengupta M; Chatterjee U; Ghosh D
Indian J Pathol Microbiol; 2021; 64(3):559-562. PubMed ID: 34341273
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Sertoli-Leydig Cell Tumor With Heterologous Hepatocytes and a Hepatocellular Carcinomatous Element.
Yamamoto S; Sakai Y
Int J Gynecol Pathol; 2019 May; 38(3):247-252. PubMed ID: 29620585
[TBL] [Abstract][Full Text] [Related]
16. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
[TBL] [Abstract][Full Text] [Related]
17. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Sertoli-Leydig Cell Tumor with Predominant Heterologous Mucinous Differentiation and Foci of Hepatocytic Differentiation: Case Report and Review of The Literature.
Liang L; Menzin A; Lovecchio JL; Navarro MD
Ann Clin Lab Sci; 2015; 45(3):348-51. PubMed ID: 26116602
[TBL] [Abstract][Full Text] [Related]
19. Sertoli Leydig cell tumor with heterologous gastrointestinal epithelium: a case report.
Mathur SR; Bhatla N; Rao IS; Singh MK
Indian J Pathol Microbiol; 2003 Jan; 46(1):91-3. PubMed ID: 15027740
[TBL] [Abstract][Full Text] [Related]
20. [Ovarian Sertoli-Leydig tumor: A tricky tumor].
Brandone N; Borrione C; Rome A; Maues de Paula A
Ann Pathol; 2018 Apr; 38(2):131-136. PubMed ID: 29398147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
